These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 16455073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
    Tramontana M, Lecci A, Meini S, Montserrat X, Pascual J, Giuliani S, Quartara L, Maggi CA.
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
    [Abstract] [Full Text] [Related]

  • 3. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.
    Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL.
    Pharmacol Rev; 2005 Mar; 57(1):27-77. PubMed ID: 15734727
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F, Meini S, Cucchi P, Catalani C, Giuliani S, Zappitelli S, Rotondaro L, Quartara L, Giolitti A, Maggi CA.
    Eur J Pharmacol; 2004 May 03; 491(2-3):121-5. PubMed ID: 15140628
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G, Bouthillier J, Marceau F.
    Biol Chem; 2006 Feb 03; 387(2):189-94. PubMed ID: 16497151
    [Abstract] [Full Text] [Related]

  • 10. Bradykinin receptor antagonists--a review of the patent literature 2005-2008.
    Fincham CI, Bressan A, Paris M, Rossi C, Fattori D.
    Expert Opin Ther Pat; 2009 Jul 03; 19(7):919-41. PubMed ID: 19552510
    [Abstract] [Full Text] [Related]

  • 11. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
    Prediger RD, Medeiros R, Pandolfo P, Duarte FS, Passos GF, Pesquero JB, Campos MM, Calixto JB, Takahashi RN.
    Neuroscience; 2008 Feb 06; 151(3):631-43. PubMed ID: 18191900
    [Abstract] [Full Text] [Related]

  • 12. Vascular B1 kinin receptors in patients with congestive heart failure.
    Lang NN, Cruden NL, Tse GH, Bloomfield P, Ludlam CA, Fox KA, Newby DE.
    J Cardiovasc Pharmacol; 2008 Nov 06; 52(5):438-44. PubMed ID: 19033823
    [Abstract] [Full Text] [Related]

  • 13. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
    Charignon D, Späth P, Martin L, Drouet C.
    Expert Opin Pharmacother; 2012 Oct 06; 13(15):2233-47. PubMed ID: 22970904
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
    Cialdai C, Giuliani S, Valenti C, Tramontana M, Maggi CA.
    J Pharmacol Exp Ther; 2009 Dec 06; 331(3):1025-32. PubMed ID: 19745108
    [Abstract] [Full Text] [Related]

  • 16. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats.
    Werner MF, Kassuya CA, Ferreira J, Zampronio AR, Calixto JB, Rae GA.
    Neuropharmacology; 2007 Jul 06; 53(1):48-57. PubMed ID: 17555775
    [Abstract] [Full Text] [Related]

  • 17. Modulation of allergic and immune complex-induced lung inflammation by bradykinin receptor antagonists.
    Gama Landgraf R, Jancar S, Steil AA, Sirois P.
    Inflamm Res; 2004 Feb 06; 53(2):78-83. PubMed ID: 15021973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Bradykinin antagonist: current status and perspective].
    Hirayama Y, Kayakiri H.
    Nihon Yakurigaku Zasshi; 2002 Jan 06; 119(1):45-53. PubMed ID: 11862756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.